Brian J Minnillo1, Matthew J Maurice1, Nicholas Schiltz2, Aiswarya C Pillai2, Siran M Koroukian2, Firouz Daneshgari1, Sim P Kim3, Robert Abouassaly1. 1. Urological Institute, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH; 2. Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH; ; Population Health and Outcomes Research Core, Clinical and Translational Science Collaborative, Cleveland, OH. 3. Urological Institute, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH; ; Yale University, COPPER Center, New Haven, CT;
Abstract
INTRODUCTION: We sought to determine the patient and provider-related factors associated with readmission after radical cystectomy (RC) for bladder cancer. In this era of healthcare reform, hospital performance measures, such as readmission, are beginning to affect provider reimbursement. Given its high readmission rate, RC could be a target for quality improvement. METHODS: We reviewed bladder cancer patients who underwent RC in California's State Inpatient Database (2005-2009) of the Healthcare Cost and Utilization Project. We examined patient-(e.g., race, discharge disposition) and provider-related factors (e.g., volume) and evaluated their association with 30-day readmission. Multivariable logistic regression was used to examine associations of interest. RESULTS: Overall, 22.8% (n = 833) of the 3649 patients who underwent RC were readmitted within 30 days. Regarding disposition, 34.8%, 50.8%, and 12.2% were discharged home, home with home healthcare, and to a post-acute care facility (PACF), respectively. Within 30 days, 20.3%, 20.9%, and 42.3% were discharged home, home with home healthcare, and to a PACF were readmitted, respectively. African Americans (odds ratio [OR] 1.64, 95% confidence interval [CI] 1.07-2.50), having ≥2 comorbidities (OR 1.42, 95% CI 1.06-1.91), receiving a neobladder (OR 1.45, 95% CI 1.09-1.93), and discharged to a PACF (OR 3.79, 95% CI 2.88-4.98) were independent factors associated with readmission. Hospital stays ≥15 days were associated with less readmission (OR 0.43, 95% CI 0.27-0.67, p = 0.0002). Procedure volume was not associated with complication, in-hospital mortality, or readmission. CONCLUSIONS: About one-fifth of patients undergoing RC are readmitted. Patients who are discharged to a PACF, African American, and who have more extensive comorbidities tend to experience more readmissions. Increased efforts with care coordination among these patients may help reduce readmissions.
INTRODUCTION: We sought to determine the patient and provider-related factors associated with readmission after radical cystectomy (RC) for bladder cancer. In this era of healthcare reform, hospital performance measures, such as readmission, are beginning to affect provider reimbursement. Given its high readmission rate, RC could be a target for quality improvement. METHODS: We reviewed bladder cancerpatients who underwent RC in California's State Inpatient Database (2005-2009) of the Healthcare Cost and Utilization Project. We examined patient-(e.g., race, discharge disposition) and provider-related factors (e.g., volume) and evaluated their association with 30-day readmission. Multivariable logistic regression was used to examine associations of interest. RESULTS: Overall, 22.8% (n = 833) of the 3649 patients who underwent RC were readmitted within 30 days. Regarding disposition, 34.8%, 50.8%, and 12.2% were discharged home, home with home healthcare, and to a post-acute care facility (PACF), respectively. Within 30 days, 20.3%, 20.9%, and 42.3% were discharged home, home with home healthcare, and to a PACF were readmitted, respectively. African Americans (odds ratio [OR] 1.64, 95% confidence interval [CI] 1.07-2.50), having ≥2 comorbidities (OR 1.42, 95% CI 1.06-1.91), receiving a neobladder (OR 1.45, 95% CI 1.09-1.93), and discharged to a PACF (OR 3.79, 95% CI 2.88-4.98) were independent factors associated with readmission. Hospital stays ≥15 days were associated with less readmission (OR 0.43, 95% CI 0.27-0.67, p = 0.0002). Procedure volume was not associated with complication, in-hospital mortality, or readmission. CONCLUSIONS: About one-fifth of patients undergoing RC are readmitted. Patients who are discharged to a PACF, African American, and who have more extensive comorbidities tend to experience more readmissions. Increased efforts with care coordination among these patients may help reduce readmissions.
Authors: C J Stimson; Sam S Chang; Daniel A Barocas; John E Humphrey; Sanjay G Patel; Peter E Clark; Joseph A Smith; Michael S Cookson Journal: J Urol Date: 2010-08-17 Impact factor: 7.450
Authors: Michael T Kassin; Rachel M Owen; Sebastian D Perez; Ira Leeds; James C Cox; Kurt Schnier; Vjollca Sadiraj; John F Sweeney Journal: J Am Coll Surg Date: 2012-06-21 Impact factor: 6.113
Authors: G R Prout; M N Wesley; R S Greenberg; V W Chen; C C Brown; A W Miller; R S Weinstein; S J Robboy; M A Haynes; R S Blacklow; B K Edwards Journal: Cancer Date: 2000-09-15 Impact factor: 6.860
Authors: Michael Hu; Bruce L Jacobs; Jeffrey S Montgomery; Chang He; Jun Ye; Yun Zhang; Julien Brathwaite; Todd M Morgan; Khaled S Hafez; Alon Z Weizer; Scott M Gilbert; Cheryl T Lee; Mariel S Lavieri; Jonathan E Helm; Brent K Hollenbeck; Ted A Skolarus Journal: Cancer Date: 2014-01-29 Impact factor: 6.860
Authors: Raza S Johar; Matthew H Hayn; Andrew P Stegemann; Kamran Ahmed; Piyush Agarwal; M Derya Balbay; Ashok Hemal; Adam S Kibel; Fred Muhletaler; Kenneth Nepple; John G Pattaras; James O Peabody; Joan Palou Redorta; Koon-Ho Rha; Lee Richstone; Matthias Saar; Francis Schanne; Douglas S Scherr; Stefan Siemer; Michael Stökle; Alon Weizer; Peter Wiklund; Timothy Wilson; Michael Woods; Bertrum Yuh; Khurshid A Guru Journal: Eur Urol Date: 2013-01-16 Impact factor: 20.096
Authors: Jason F Flamiatos; Yiyi Chen; William E Lambert; Ann Martinez Acevedo; Thomas M Becker; Jasper C Bash; Christopher L Amling Journal: J Robot Surg Date: 2018-06-08
Authors: Peter S Kirk; Ted A Skolarus; Bruce L Jacobs; Yongmei Qin; Benjamin Li; Michael Sessine; Xiang Liu; Kevin Zhu; Scott M Gilbert; Brent K Hollenbeck; Ken Urish; Jonathan Helm; Mariel S Lavieri; Tudor Borza Journal: BJU Int Date: 2019-08-11 Impact factor: 5.588
Authors: Ahmet Murat Aydin; Richard R Reich; Biwei Cao; Salim K Cheriyan; Ali Hajiran; Logan Zemp; Alice Yu; Michael A Poch; Wade J Sexton; Roger Li; Scott M Gilbert Journal: Urol Oncol Date: 2021-10-08 Impact factor: 3.498
Authors: Meera R Chappidi; Max Kates; C J Stimson; Michael H Johnson; Phillip M Pierorazio; Trinity J Bivalacqua Journal: J Urol Date: 2016-08-18 Impact factor: 7.450